Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Clozapine N-oxide: Precision Chemogenetics for Neuronal Modu
2026-05-22
Clozapine N-oxide (CNO) is the gold-standard chemogenetic actuator, enabling highly selective and reversible neuronal activity modulation in vivo and in vitro. This article demystifies CNO’s workflow integration, protocol fine-tuning, and troubleshooting for advanced neuroscience research, with actionable insights inspired by cutting-edge hippocampal targeting studies.
-
Angiotensin II-HIF-1α Axis Drives Radioresistance in NPC
2026-05-21
This study elucidates how local angiotensin II (Ang II) promotes radioresistance in nasopharyngeal carcinoma (NPC) by suppressing ferroptosis via the HIF-1α-HILPDA axis. The findings highlight actionable molecular targets to improve radiotherapy efficacy and suggest that combined inhibition of Ang II signaling and induction of ferroptosis may enhance NPC radiosensitivity.
-
Carfilzomib (PR-171): Proteasome Inhibition in Epigenetic Th
2026-05-21
Explore how Carfilzomib (PR-171) enables advanced proteasome inhibition in cancer research, with a unique focus on its role in epigenetic therapy and combinatorial strategies. Uncover protocol nuances, new synergy insights, and translational implications.
-
Verbascoside: Precision PKC/NF-κB Inhibitor for Osteoclastog
2026-05-20
Verbascoside from APExBIO offers targeted PKC/NF-κB pathway inhibition, enabling high-fidelity dissection of osteoclastogenesis and neuroinflammatory processes. Its robust solubility and validated IC50 in RANKL-induced cellular models accelerate reproducible, mechanism-focused research.
-
Balsalazide Disodium Dihydrate: Optimizing Inflammation Rese
2026-05-20
Balsalazide Disodium Dihydrate unlocks robust, localized anti-inflammatory effects, making it ideal for dissecting pathomechanisms in ulcerative colitis and immunology assays. This guide delivers actionable workflows, protocol specifics, and troubleshooting strategies grounded in peer-reviewed data and product-driven evidence.
-
CKI 7 dihydrochloride: Reliable CK1 Inhibition for Cell Assa
2026-05-19
CKI 7 dihydrochloride (SKU B4936) enables robust, reproducible inhibition of Casein kinase 1 in cell viability, proliferation, and cytotoxicity assays. This article addresses common workflow pain points and illustrates, through data-driven scenarios, how CKI 7 dihydrochloride outperforms alternatives in sensitivity, selectivity, and compatibility for signaling pathway research.
-
T7 RNA Polymerase: Optimizing In Vitro RNA Synthesis Workflo
2026-05-19
Harness APExBIO’s T7 RNA Polymerase for high-yield, template-specific RNA synthesis, enabling advanced applications from RNA vaccine production to functional RNA research. Groundbreaking insights from recent lung cancer immunotherapy studies guide practical protocol enhancements, troubleshooting, and translational innovations.
-
Phosbind Acrylamide: Precision Phosphate-Binding Reagent for
2026-05-18
Phosbind Acrylamide streamlines SDS-PAGE-based protein phosphorylation analysis by enabling antibody-free, high-resolution separation of phosphorylated and non-phosphorylated proteins. Its robust phosphate specificity and workflow flexibility empower researchers to dissect dynamic phosphorylation signaling, such as the Fus3-MAPK/RNS1 cascade in fungi, with clarity and reproducibility.
-
Polyethylenimine Linear: High-Efficiency Transfection for In
2026-05-18
Polyethylenimine Linear (PEI), MW 40,000, stands out as a gold-standard DNA transfection reagent, enabling scalable, serum-compatible gene delivery from 96-well plates to bioreactors. This article details experimental workflows, troubleshooting insights, and protocol optimizations that maximize reproducibility and yield, drawing on cutting-edge research and real-world lab experience.
-
Molidustat (BAY85-3934): Redefining HIF Stabilization in Ren
2026-05-17
Explore the advanced science behind Molidustat (BAY85-3934), a novel HIF-PH inhibitor for renal anemia therapy. This article uniquely dissects its mechanistic nuance, real-world protocol implications, and the pivotal role of HIF-1α regulation—offering insights not covered in prior reviews.
-
V5 Epitope Tag Peptide: Workflow Optimization and Troublesho
2026-05-16
Leverage the V5 Epitope Tag Peptide for high-fidelity protein detection, purification, and single-molecule imaging. This guide details applied workflows, real-world troubleshooting, and new screening advances, positioning APExBIO’s V5 tag as a gold standard for reproducible, multiplexed molecular biology.
-
Enhancing Kidney-Targeted mRNA Nanoparticles via Excipients
2026-05-15
This study investigates the use of various excipients to increase the mRNA loading capacity of polymeric mesoscale nanoparticles targeting the kidney. By systematically evaluating how excipient selection influences encapsulation efficiency, cytotoxicity, and functional delivery, the research provides new insights for optimizing mRNA-based therapies in renal disease contexts.
-
KN-62: Advanced Insights into CaMKII Inhibition and Calcium
2026-05-15
Explore KN-62, a potent CaMKII inhibitor, and its nuanced role in dissecting calcium signaling and metabolic regulation. This article delivers unique, in-depth analysis and practical assay guidance for researchers using KN-62, 1-[N,O-bis-(5-isoquinolinesulphonyl)-N-methyl-L-tyrosy]-4-phenylpiperazine.
-
H3K18 Lactylation Drives NOD2-Mediated Pyroptosis in BE Astr
2026-05-14
Li et al. present a mechanistic link between glycolysis-driven histone H3K18 lactylation and NOD2 upregulation, which in turn triggers pyroptosis in astrocytes exposed to unconjugated bilirubin. These findings elucidate an epigenetic pathway central to neuroinflammatory injury in bilirubin encephalopathy and highlight metabolic-epigenetic crosstalk as a potential therapeutic target.
-
Vincristine Sulfate Workflows: Applied Cancer Research & Opt
2026-05-14
Vincristine sulfate is a gold-standard microtubule disrupter powering reproducible oncology experiments from leukemia to solid tumor models. This article demystifies protocol design, troubleshooting, and advanced uses—anchored by APExBIO’s high-purity product and latest literature insights.